Evidence map›Paper›PMID 42026214›Full record

ReviewPediatric research2026

Overview of T-cell subsets and related cytokines in Kawasaki disease.

Yufei Zhu, Shibing Xi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yufei ZhuDepartment of Pediatrics, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Shibing XiDepartment of Pediatrics, Taihe Hospital, Hubei University of Medicine, Shiyan, China. xishibing@hbmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kawasaki disease (KD) is an acute febrile inflammatory illness in children characterized by systemic vasculitis; the etiology and pathogenesis have not been fully clarified. In recent years, studies have shown that T cell-mediated immune abnormalities play an important role in the development of KD. This paper reviewed the dynamic changes of T cell subsets (e.g., Th1, Th17, Treg, etc.) and their regulatory mechanisms in KD, focusing on the molecular mechanisms of T cell-mediated cytokine storm, autoimmune response and vascular injury. In addition, this paper summarizes the research progress of T cell-targeted therapy in KD, which provides a new theoretical basis for the optimization of clinical intervention strategies. By systematically combing the roles and mechanisms of T cells in KD, aims to provide reference for further elucidation of its pathogenesis and development of novel therapeutic approaches. IMPACT: T cells exhibit different immune responses in physiological and pathological states. Different T cell subsets are functionally diverse. Different T cell subsets in patients with Kawasaki disease exhibit significant differences in activity that correlate with therapeutic efficacy. Studies of T cell subsets reveal potential immunotherapeutic targets and improve our understanding of Kawasaki disease.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.